SCHEMBL6972613

SCHEMBL6972613

Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3CCCC(CC(=O)O)c4ccccc43)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 14/20 0.59
AVPR1A P37288 9/20 0.59
OXTR P30559 2/20 0.56
AVPR1B P47901 2/20 0.56
ABCB11 O95342 1/20 0.56
HTR1A P08908 1/20 0.56
CHRM1 P11229 1/20 0.56
SLC6A4 P31645 1/20 0.56
ADRA1A P35348 1/20 0.56
OPRM1 P35372 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8961742 0.91 AVPR2 (0.56) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL6962598 0.90 AVPR2 (0.61) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL6965061 0.90 AVPR2 (0.65) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL6965024 0.89 AVPR2 (0.57) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL6966369 0.85 AVPR2 (0.77) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL8961694 0.84 AVPR2 (0.72) AVPR2AVPR1AOXTRAVPR1B
SCHEMBL6965154 0.82 AVPR2 (0.56) AVPR2AVPR1AAVPR1BABCB11HTR1A
SCHEMBL7087152 0.81 AVPR2 (0.71) AVPR2AVPR1AOXTRAVPR1B
SCHEMBL6970595 0.81 AVPR2 (0.54) AVPR2AVPR1AOXTRAVPR1BABCB11
SCHEMBL7345800 0.81 AVPR2 (0.77) AVPR2AVPR1AOXTRAVPR1BABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620216-B1 Benzamide derivatives and their use as vasopressin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2003-01-08 EP disclosed
US-5521170-A VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-05-28 US disclosed
EP-0620216-A1 Benzamide derivatives and their use as vasopressin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-10-19 EP disclosed